Perinatal health screenings and treatment.
What changed between versions
The term 'perinatal maternal mental health condition' used throughout the amended assembly version is replaced with 'maternal mental health condition' in the enrolled version. The definition is narrowed from covering conditions during 'pregnancy, the postpartum period, or the perinatal period' to only 'the pregnancy or the postpartum period.'
Screening requirements are narrowed. The amended assembly version required screenings 'during pregnancy and during the postpartum and perinatal periods.' The enrolled version requires screenings 'during pregnancy and one or more mental health screenings to be conducted during the postpartum period.'
The amended assembly version included annual reporting requirements (paragraphs 3 and 4) obligating health care service plans and insurers to report utilization and outcomes of case management services to the department and publicly post that information on their websites. These are removed in the enrolled version.
The amended assembly version included a standalone subdivision (c) in Section 123640 requiring a licensed health care practitioner who provides perinatal care to 'diagnose and treat' patients with perinatal mental health conditions. This is removed; the enrolled version instead provides a referral option allowing practitioners to satisfy screening and evaluation requirements by referring to another authorized practitioner.
Case management or care coordination is now triggered specifically by a positive screen for a maternal mental health condition, rather than being provided broadly 'during the perinatal period' as in the amended assembly version. It must be provided in accordance with the plan's or insurer's existing programs.
The encouragement language for treatment improvement is simplified from 'medication and digital therapeutics outpatient prescription drugs approved for perinatal maternal health by the FDA' to 'outpatient prescription drugs approved for maternal mental health by the FDA,' removing the reference to digital therapeutics.